Association between gene expression signatures and outcomes of pembrolizumab (pembro) and paclitaxel (pac) in advanced gastric cancer (GC): Exploratory analysis from KEYNOTE-061
Shitara, K. Di Bartolomeo, M. Mandala, M. Ryu, M. H. Caglevic, C. Olesinski, T. Chung, H. C. Muro, K. Goekkurt, E. McDermott, R. S.
Shitara, K.
Di Bartolomeo, M.
Mandala, M.
Ryu, M. H.
Caglevic, C.
Olesinski, T.
Chung, H. C.
Muro, K.
Goekkurt, E.
McDermott, R. S.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Shitara K, Di Bartolomeo M, Mandala M, Ryu MH, Caglevic C, Olesinski T, et al. Association between gene expression signatures and outcomes of pembrolizumab (pembro) and paclitaxel (pac) in advanced gastric cancer (GC): Exploratory analysis from KEYNOTE-061. Cancer Research. 2022 Jun;82(12). PubMed PMID: WOS:000892509505169.